Aktiespot

Sanofi India Limited (SANOFI INDIA LTD) Aktie

SANOFI.BO

Geschlossen
₹3,183.75+3.30 (+0.10%)
Chart wird geladen...

SANOFI INDIA LTD

Eröffnung3,206.90
Hoch3,220.00
Tief3,175.00
Volumen1.16k
P/E23.70
Marktkapitalisierung73.32B
52-Wochen-Hoch6,399.95
52-Wochen-Tief3,057.60
Durchschn. Volumen2.1k
Dividende7.54%
Beta0.17
EPS134.35

Über Sanofi India Limited (SANOFI INDIA LTD) Aktie

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.

Unternehmensinformationen

Börse: BSE (BSE)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Generelt
Adresse:
Sanofi House
400072 Mumbai, India
Telefon: + 91 22 2803 2000

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
3,700.00
16.2%
Durchschnittliches Kursziel
4,579.00
43.8%
Median Kursziel
4,487.00
40.9%
Höchstes Kursziel
5,550.00
74.3%

Andere sehen auch: